WBA names Dixon global controller
Heather Dixon has been named senior vice president, global controller and chief accounting officer by Walgreens Boots Alliance Inc, effective March 18. Dixon will join WBA from Aetna Inc.
Latest
West Virginia Medicaid saves $54.4 million with prescription drug carve-out
When the West Virginia Medicaid agency started managing the Medicaid managed care prescription drug benefit directly in July 2017, state officials were relying on an actuarial study forecasting a $30 million savings for the state.
Genoa Healthcare participating in opioid treatment study
A new National Institutes of Health (NIH)-funded study is underway that’s examining the effectiveness of putting pharmacists in the role of caring of people with substance use disorder.
Rite Aid announces leadership restructuring
CAMP HILL, PA – Rite Aid Corp. announced Tuesday a leadership transition plan and an organizational restructuring to better align its structure with the company’s operations and to reduce costs. As part of the leadership transition, John Standley will step down as chief executive officer.
Sharpless named acting FDA commissioner
Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and Drug Administration next month. Health and Human Services Secretary Alex Azar said Tuesday that Sharpless will take the reins of the FDA after the resignation of Scott Gottlieb.
Five HDA member companies honored
The Healthcare Distribution Alliance recognized AbbVie US; AmerisourceBergen Corporation; Genentech, a Member of the Roche Group; McKesson Corporation and Pfizer, Inc., with the 2019 Distribution Management Award (DMA) for the MediLedger Project, a blockchain-enabled traceability initiative.
IRI’s Appel shares perspective on technology at Growth Summit
At the annual IRI Growth Summit IRI president and chief executive officer Andrew Appel Tuesday discussed his views on data and technology as the next enabler of competitive advantage.
IRI unveils findings of new CBD attitude and usage study
IRI Tuesday released findings of a new study focused on understanding the attitudes and usage motivations of legal adult cannabis users, and the projected impact of further legalization on consumer product purchase habits.
CURE Pharmaceutical to manufacture pharmaceuticals using whole cannabis plant
OXNARD, Calif. – CURE Pharmaceutical Tuesday announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol (CBD).
IRI Growth Summit: “Powering the path forward”
IRI‘s 2019 Growth Summit kicked off Monday at the new Gaylord Rockies Resort and Convention Center in Denver, Colo. with a record attendance of approximately 1,600 participants expected during the three-day event.
Tastykake debuts Scoop Shop line
Tastykake is partnering with another Philly icon, Bassetts Ice Cream Co., to launch Cookies and Crème Mini Donuts, the first offering from Tastykake Scoop Shop, an ice cream-inspired line of sweet snacks.
Retail sales bounce back in January
WASHINGTON – Retail sales rebounded in January, the National Retail Federation said on Monday. Sales increased by 1.3% seasonally adjusted from December and by 3.6% unadjusted year-over-year. The numbers exclude automobile dealers, gasoline stations and restaurants.
New Extra Refreshers gum hits store shelves
Extra gum, the No. 1 selling gum brand in the U.S., announced Monday the launch of Extra Refreshers gum, the first-ever soft chew added to the brand’s portfolio. Bursting with intense freshness, the new soft chew comes in three exciting flavors: Spearmint, Polar Ice and Tropical Mist.
Kimberly-Clark nominates Maclin and Shive to board
Kimberly-Clark Corp. announced that S. Todd Maclin and Dunia Shive have been nominated for election to its board of directors at the company’s 2019 Annual Meeting of Shareholders on May 2. Current board members John F. Bergstrom and James M. Jenness will be retiring in 2019.
Lupin receives FDA approval for generic Lipitor
Lupin announced that it has received approval for its atorvastatin calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Pfizer’s Lipitor Tablets, 10 mg, 20 mg, 40 mg and 80 mg.
Dove Men+Care unites rivals for March Madness
NCAA March Madness is known for some of the most intense and deep-seated rivalries in sports history. That’s why, this March Madness, Dove Men+Care will bring college basketball’s biggest rivals together by turning the jersey into a symbol of unity.